Serum-free light-chain assay: clinical utility and limitations

In the last decade, the introduction of the serum-free light-chain (sFLC) assay has been an important advance in the diagnosis and management of plasma cell dyscrasias, particularly monoclonal light-chain diseases. The immunoassay was developed to detect free light chains in serum by using anti-FLC...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of Clinical Biochemistry 2014-09, Vol.51 (5), p.528-542
Hauptverfasser:	Bhole, Malini V, Sadler, Ross, Ramasamy, Karthik
Format:	Artikel
Sprache:	eng
Schlagworte:	Amyloidosis - blood Humans Immunoassay - methods Immunoglobulin Light Chains - blood Immunoglobulin Light-chain Amyloidosis Multiple Myeloma - blood Nephelometry and Turbidimetry - methods Paraproteinemias - blood Paraproteinemias - diagnosis Prognosis Reference Values
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!